Correlation Between Citigroup and Ovid Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and Ovid Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Ovid Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Ovid Therapeutics, you can compare the effects of market volatilities on Citigroup and Ovid Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Ovid Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Ovid Therapeutics.

Diversification Opportunities for Citigroup and Ovid Therapeutics

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Citigroup and Ovid is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Ovid Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ovid Therapeutics and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Ovid Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ovid Therapeutics has no effect on the direction of Citigroup i.e., Citigroup and Ovid Therapeutics go up and down completely randomly.

Pair Corralation between Citigroup and Ovid Therapeutics

Taking into account the 90-day investment horizon Citigroup is expected to generate 0.61 times more return on investment than Ovid Therapeutics. However, Citigroup is 1.63 times less risky than Ovid Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Ovid Therapeutics is currently generating about -0.15 per unit of risk. If you would invest  6,245  in Citigroup on August 25, 2024 and sell it today you would earn a total of  739.00  from holding Citigroup or generate 11.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Citigroup  vs.  Ovid Therapeutics

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.
Ovid Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ovid Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Citigroup and Ovid Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and Ovid Therapeutics

The main advantage of trading using opposite Citigroup and Ovid Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Ovid Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ovid Therapeutics will offset losses from the drop in Ovid Therapeutics' long position.
The idea behind Citigroup and Ovid Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences